scholarly journals Lectin Protein as a Promising Component to Functionalize Micelles, Liposomes and Lipid NPs against Coronavirus

Biomedicines ◽  
2020 ◽  
Vol 8 (12) ◽  
pp. 580
Author(s):  
Mehran Alavi ◽  
Kofi Asare-Addo ◽  
Ali Nokhodchi

The outbreak of a novel strain coronavirus as the causative agent of COVID-19 pneumonia, first identified in Wuhan, China in December 2019, has resulted in considerable focus on virulence abilities of coronavirus. Lectins are natural proteins with the ability to bind specific carbohydrates related to various microorganisms, including viruses, bacteria, fungi and parasites. Lectins have the ability to agglutinate and neutralize these pathogeneses. The delivery of the encapsulated antiviral agents or vaccines across the cell membrane can be possible by functionalized micellar and liposomal formulations. In this mini-review, recent advances and challenges related to important lectins with inhibition activities against coronaviruses are presented to obtain a novel viewpoint of microformulations or nanoformulations by micellar and liposomal cell-binding carriers.

2021 ◽  
pp. 2002081
Author(s):  
Faisal Raza ◽  
Hajra Zafar ◽  
Shulei Zhang ◽  
Zul Kamal ◽  
Jing Su ◽  
...  

Drug Delivery ◽  
2021 ◽  
Vol 28 (1) ◽  
pp. 1109-1119
Author(s):  
Rongtao Zhang ◽  
Siqiong Wu ◽  
Qian Ding ◽  
Qingze Fan ◽  
Yan Dai ◽  
...  

2017 ◽  
Vol 8 (10) ◽  
pp. 7098-7105 ◽  
Author(s):  
Kaixiang Zhang ◽  
Ruijie Deng ◽  
Yupeng Sun ◽  
Ling Zhang ◽  
Jinghong Li

DNA nano-spring multivalent ligands for reversibly controlling the nanoscale distribution of cell binding ligands and regulating the cell behavior.


F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 269 ◽  
Author(s):  
Karin Hellner ◽  
Lucy Dorrell

High-risk human papillomaviruses (hrHPV) are responsible for anogenital and oropharyngeal cancers, which together account for at least 5% of cancers worldwide. Industrialised nations have benefitted from highly effective screening for the prevention of cervical cancer in recent decades, yet this vital intervention remains inaccessible to millions of women in low- and middle-income countries (LMICs), who bear the greatest burden of HPV disease. While there is an urgent need to increase investment in basic health infrastructure and rollout of prophylactic vaccination, there are now unprecedented opportunities to exploit recent scientific and technological advances in screening and treatment of pre-invasive hrHPV lesions and to adapt them for delivery at scale in resource-limited settings. In addition, non-surgical approaches to the treatment of cervical intraepithelial neoplasia and other hrHPV lesions are showing encouraging results in clinical trials of therapeutic vaccines and antiviral agents. Finally, the use of next-generation sequencing to characterise the vaginal microbial environment is beginning to shed light on host factors that may influence the natural history of HPV infections. In this article, we focus on recent advances in these areas and discuss their potential for impact on HPV disease.


Small ◽  
2019 ◽  
Vol 15 (1) ◽  
pp. 1970002
Author(s):  
Xu Zhen ◽  
Penghui Cheng ◽  
Kanyi Pu

2020 ◽  
Vol 30 (39) ◽  
pp. 2003559 ◽  
Author(s):  
Wen‐Long Liu ◽  
Mei‐Zhen Zou ◽  
Si‐Yong Qin ◽  
Yin‐Jia Cheng ◽  
Yi‐Han Ma ◽  
...  

2021 ◽  
Author(s):  
Mian Wang ◽  
Yuanfeng Xin ◽  
Hao Cao ◽  
Wanlu Li ◽  
Yifei Hua ◽  
...  

Studies of nanomedicine have achieved dramatic progress in recent decades.


Small ◽  
2018 ◽  
Vol 15 (1) ◽  
pp. 1804105 ◽  
Author(s):  
Xu Zhen ◽  
Penghui Cheng ◽  
Kanyi Pu

Sign in / Sign up

Export Citation Format

Share Document